| 000 | 01668 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515013724.0 | ||
| 264 | 0 | _c20060629 | |
| 008 | 200606s 0 0 eng d | ||
| 022 | _a0269-2813 | ||
| 024 | 7 |
_a10.1111/j.1365-2036.2006.02774.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVeldhuyzen van Zanten, S J O | |
| 245 | 0 | 0 |
_aValidation of a 7-point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials. _h[electronic resource] |
| 260 |
_bAlimentary pharmacology & therapeutics _cFeb 2006 |
||
| 300 |
_a521-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Validation Study | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnti-Ulcer Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aDyspepsia _xcomplications |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOmeprazole _xtherapeutic use |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aChiba, N | |
| 700 | 1 | _aArmstrong, D | |
| 700 | 1 | _aBarkun, A N | |
| 700 | 1 | _aThomson, A B R | |
| 700 | 1 | _aMann, V | |
| 700 | 1 | _aEscobedo, S | |
| 700 | 1 | _aChakraborty, B | |
| 700 | 1 | _aNevin, K | |
| 773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 23 _gno. 4 _gp. 521-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2036.2006.02774.x _zAvailable from publisher's website |
| 999 |
_c16055869 _d16055869 |
||